Literature DB >> 27890702

FOXOs in the impaired heart: New therapeutic targets for cardiac diseases.

Zhenlong Xin1, Zhiqiang Ma2, Shuai Jiang3, Dongjin Wang4, Chongxi Fan2, Shouyin Di2, Wei Hu5, Tian Li5, Junjun She6, Yang Yang7.   

Abstract

Cardiac diseases have a high morbidity and mortality and affect the global population. Based on recent accumulating evidence, Forkhead box O (FOXOs) play important roles in cardiac diseases. Therefore, a summary of the current literature on the molecular mechanisms and roles of FOXOs in the heart will provide valuable information. In this review, we first briefly introduce the molecular features of FOXOs. Then, we discuss the regulation and cardiac actions of the FOXO pathways. Based on this background, we expand our discussion to the roles of FOXOs in several major cardiac diseases, such as ischemic cardiac diseases, diabetic cardiomyopathy and myocardial hypertrophy. Then, we describe some methodological problems associated with the FOXO gene-modified animal models. Finally, we discuss potential future directions. The information reviewed here may be significant for the design of future studies and may increase the potential of FOXOs as therapeutic targets.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac regeneration; Diabetic cardiomyopathy; Forkhead box O; Ischemic cardiac diseases; Myocardial hypertrophy

Mesh:

Substances:

Year:  2016        PMID: 27890702     DOI: 10.1016/j.bbadis.2016.11.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  19 in total

1.  Quantifying Tissue-Specific Overexpression of FOXO in Drosophila via mRNA Fluorescence In Situ Hybridization Using Branched DNA Probe Technology.

Authors:  Anna C Blice-Baum; Georg Vogler; Meera C Viswanathan; Bosco Trinh; Worawan B Limpitikul; Anthony Cammarato
Journal:  Methods Mol Biol       Date:  2019

2.  Microgravity-induced stress mechanisms in human stem cell-derived cardiomyocytes.

Authors:  Aviseka Acharya; Harshal Nemade; Symeon Papadopoulos; Jürgen Hescheler; Felix Neumaier; Toni Schneider; Krishna Rajendra Prasad; Khadija Khan; Ruth Hemmersbach; Eduardo Gade Gusmao; Athanasia Mizi; Argyris Papantonis; Agapios Sachinidis
Journal:  iScience       Date:  2022-06-11

Review 3.  Role of Forkhead Box Protein O1 (FoxO1) in Stroke: A Literature Review.

Authors:  Sichao Guo; Ruchi Mangal; Chaitu Dandu; Xiaokun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

4.  Fork Head Box Class O1 (FOXO1) Activates Bim Expression to Mediate Cardiac Apoptosis in Chronic Intermittent Hypoxia-Induced Cardiac Hypertrophy.

Authors:  Guangcai Li; Meng Jin; Yuan He; Jie Ren; Minghua Zhang; Yilin Chen; Xiong Lan; Jianhua Zhong; Huiguo Liu
Journal:  Med Sci Monit       Date:  2017-07-24

5.  Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy.

Authors:  Peng Duan; Jinxin Wang; Yang Li; Shiqiang Wei; Feng Su; Sanlin Zhang; Yuhui Duan; Lin Wang; Qinglei Zhu
Journal:  Int J Mol Med       Date:  2018-08-21       Impact factor: 4.101

6.  Deletion of Sulfonylurea Receptor 2 in the Adult Myocardium Enhances Cardiac Glucose Uptake and Is Cardioprotective.

Authors:  Gregory Aubert; David Y Barefield; Alexis R Demonbreun; Mohun Ramratnam; Katherine S Fallon; James L Warner; Ann E Rossi; Michele Hadhazy; Jonathan C Makielski; Elizabeth M McNally
Journal:  JACC Basic Transl Sci       Date:  2019-04-29

7.  Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.

Authors:  Márta Sárközy; Renáta Gáspár; Ágnes Zvara; Andrea Siska; Bence Kővári; Gergő Szűcs; Fanni Márványkövi; Mónika G Kovács; Petra Diószegi; László Bodai; Nóra Zsindely; Márton Pipicz; Kamilla Gömöri; Krisztina Kiss; Péter Bencsik; Gábor Cserni; László G Puskás; Imre Földesi; Thomas Thum; Sándor Bátkai; Tamás Csont
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

8.  miR-19a/b-3p promotes inflammation during cerebral ischemia/reperfusion injury via SIRT1/FoxO3/SPHK1 pathway.

Authors:  Feng Zhou; Yu-Kai Wang; Cheng-Guo Zhang; Bing-Yi Wu
Journal:  J Neuroinflammation       Date:  2021-05-29       Impact factor: 8.322

9.  Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.

Authors:  Yang Liu; Shuang Li; Zhanqun Gao; Shuangjia Li; Qingyun Tan; Yanmei Li; Dongwei Wang; Qingdong Wang
Journal:  Cardiovasc Toxicol       Date:  2021-05-21       Impact factor: 3.231

10.  PERK-Mediated Suppression of microRNAs by Sildenafil Improves Mitochondrial Dysfunction in Heart Failure.

Authors:  Takashi Shimizu; Akashi Taguchi; Yoshiki Higashijima; Naoko Takubo; Yasuharu Kanki; Yoshihiro Urade; Youichiro Wada
Journal:  iScience       Date:  2020-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.